137 related articles for article (PubMed ID: 14612143)
1. In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry.
Greco PG; Garris PA
Eur J Pharmacol; 2003 Oct; 479(1-3):117-25. PubMed ID: 14612143
[TBL] [Abstract][Full Text] [Related]
2. Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission.
Wu Q; Reith ME; Kuhar MJ; Carroll FI; Garris PA
J Neurosci; 2001 Aug; 21(16):6338-47. PubMed ID: 11487657
[TBL] [Abstract][Full Text] [Related]
3. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
Budygin EA; John CE; Mateo Y; Jones SR
J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
[TBL] [Abstract][Full Text] [Related]
4. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
[TBL] [Abstract][Full Text] [Related]
5. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
6. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
7. Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry.
Wu Q; Reith ME; Wightman RM; Kawagoe KT; Garris PA
J Neurosci Methods; 2001 Dec; 112(2):119-33. PubMed ID: 11716947
[TBL] [Abstract][Full Text] [Related]
8. Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate-putamen.
Izenwasser S; Newman AH; Katz JL
Eur J Pharmacol; 1993 Oct; 243(2):201-5. PubMed ID: 8276070
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transport function is elevated in cocaine users.
Mash DC; Pablo J; Ouyang Q; Hearn WL; Izenwasser S
J Neurochem; 2002 Apr; 81(2):292-300. PubMed ID: 12064476
[TBL] [Abstract][Full Text] [Related]
10. Cocaine induction of dopamine transporter trafficking to the plasma membrane.
Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L
Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869
[TBL] [Abstract][Full Text] [Related]
11. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
Kahlig KM; Galli A
Eur J Pharmacol; 2003 Oct; 479(1-3):153-8. PubMed ID: 14612146
[TBL] [Abstract][Full Text] [Related]
12. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
[TBL] [Abstract][Full Text] [Related]
13. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
14. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of dopamine transporter mRNA in the rat brain: mapping, effects of "binge" cocaine administration and withdrawal.
Maggos CE; Spangler R; Zhou Y; Schlussman SD; Ho A; Kreek MJ
Synapse; 1997 May; 26(1):55-61. PubMed ID: 9097405
[TBL] [Abstract][Full Text] [Related]
17. Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders: behavioral and electrochemical recordings in freely moving rats.
Sabeti J; Gerhardt GA; Zahniser NR
J Pharmacol Exp Ther; 2002 Sep; 302(3):1201-11. PubMed ID: 12183681
[TBL] [Abstract][Full Text] [Related]
18. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ
Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532
[TBL] [Abstract][Full Text] [Related]
19. Role of the dopamine transporter in the differential cocaine-induced locomotor activation of inbred long-sleep and short-sleep mice.
Hanania T; Gulley JM; Salaz DO; Larson GA; Zahniser NR
Neuropsychopharmacology; 2004 Oct; 29(10):1814-22. PubMed ID: 15199369
[TBL] [Abstract][Full Text] [Related]
20. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine.
Izenwasser S; Coy AE; Ladenheim B; Loeloff RJ; Cadet JL; French D
Eur J Pharmacol; 1999 Jun; 373(2-3):187-93. PubMed ID: 10414438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]